HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 17-19, 2025

March 17 -19, 2025 | Rome, Italy
Orphan Drugs 2023

Cyber security role for rare diseases and pharmaceutical industry

Speaker at Orphan Drugs and Rare Diseases 2023 - Kranthi Kumar Singamaneni
Chaitanya Bharathi Institute of Technology, India
Title : Cyber security role for rare diseases and pharmaceutical industry

Abstract:

Cyber security is the practice of defending computers, servers, mobile devices, electronic systems, networks, and data from malicious attacks. It's also known as information technology security or electronic information security. Cybersecurity plays a vital role in the context of rare diseases and the pharmaceutical industry, ensuring the protection of sensitive data, patient privacy, and intellectual property related to rare diseases and pharmaceutical research. The following are some specific aspects of the cybersecurity role in this domain:

Patient Data Protection: For patients with rare diseases, their medical records and personal information are highly sensitive. Cybersecurity measures are crucial in healthcare institutions to safeguard patient data from unauthorized access, data breaches, and potential identity theft.

Research Data Security: Rare disease research involves extensive data collection and analysis. Cybersecurity safeguards help protect research data, ensuring the integrity and confidentiality of clinical trial results, genomic data, and other research findings.

Intellectual Property Protection: The pharmaceutical industry invests significant resources in research and development of rare disease treatments. Cybersecurity is essential to protect valuable intellectual property, trade secrets, and proprietary data related to potential drug candidates and their formulations.

Clinical Trial Security: Cybersecurity measures are critical during clinical trials of rare disease treatments to prevent data manipulation, unauthorized access to trial results, or any tampering that could impact patient safety and drug efficacy.

Preventing Counterfeit Drugs: Cybersecurity plays a role in preventing the distribution of counterfeit drugs, especially for rare disease medications. Implementing secure supply chain management and digital tracking systems can help verify the authenticity of drugs.

Medical Device Security: Some rare diseases require specialized medical devices. Ensuring the security of these devices is vital to prevent cyber threats that could compromise patient safety or privacy.

Data Sharing and Collaboration: Collaboration among researchers, pharmaceutical companies, and healthcare institutions is essential for rare disease research. Cybersecurity measures enable secure data sharing, fostering collaboration without compromising sensitive information.

Pharmaceutical Infrastructure Protection: Cyber threats can target pharmaceutical companies and research institutions directly. Robust cybersecurity measures protect against data breaches, ransomware attacks, and other cyber incidents that could disrupt operations or compromise sensitive data.

Patient Trust and Reputation: Strong cybersecurity practices instill confidence in patients and stakeholders, enhancing the reputation of pharmaceutical companies and healthcare institutions involved in rare disease research and treatment.

Remote Healthcare Technologies: The increasing use of telemedicine and remote healthcare technologies in rare disease management requires robust cybersecurity to protect patient data during online consultations and remote monitoring.

By addressing these cybersecurity aspects, organizations involved in rare diseases and the pharmaceutical industry can ensure the confidentiality, integrity, and availability of critical data, promote patient trust, and contribute to advancements in research and treatments for rare diseases.

Audience Take Away Notes:

• Cyber Security basics
• Cyber security role for rare diseases
• Significance of cyber security for pharmaceutical industry
• Future directions

Biography:

Dr. S. Kranthi Kumar is a faculty member with a Ph.D. in Applied Cryptography and Cloud Security from GITAM Deemed to be University. He has M.Tech degrees in Information Technology and Computer Science from JNTU Kakinada and Acharya Nagarjuna University, respectively. With 16 years of experience in teaching, industry, and research, Dr. Kranthi Kumar brings a comprehensive skill set. He worked as a Data Specialist at IBM and focuses his research on Applied Cryptography, Network, and Cloud Security. He has published 25 research papers in reputable journals indexed by SCI, WOS, SCOPUS, and UGC. As a member of professional societies such as ISTE, CSI, IFERP, and IAENG, Dr. Kranthi Kumar actively engages with the academic community and stays updated with the latest advancements in Computer Science.

Watsapp